Other News

NHS England to Extend Reimbursement for the HeartFlow Analysis Through Innovation and Technology Payment (ITP) Program

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that NHS England has extended HeartFlow’s participation in the Innovation and Technology Payment (ITP) program for an additional year. As part of the extension, NHS England will provide reimbursement to NHS hospitals for the usage of the HeartFlow FFRct Analysis, a non-invasive cardiac test for stable […]

BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019

MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve Therapy Structural Heart Summit (TVT 2019), which will take place June 12-15 at the Sheraton Grand Chicago. The company’s Tempo® Temporary Pacing Lead will be featured in […]

Silk Road Medical Announces Key TCAR Presentations at the Society for Vascular Surgery 2019 Vascular Annual Meeting

Results Include Data from SVS TCAR Surveillance Project and ROADSTER-2 Study SUNNYVALE, Calif. – June 4, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study […]

Itamar Medical and BioTel Heart, a Division of BioTelemetry, Expand Collaboration to Offer Itamar’s Total Sleep Solution™ to BioTel Heart Cardiology Customers

CAESAREA, Israel, June 04, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea with a focus on the cardiology market, and BioTel Heart, a division of BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused […]

Edwards Lifesciences Recommends Stockholders Reject “Mini-Tender Offer” By TRC Capital Corporation

IRVINE, Calif., June 3, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received notice of an unsolicited “mini-tender offer” by TRC Capital Corporation to purchase up to 1,000,000 shares, or approximately 0.48 percent of the […]

FLEX Vessel Prep™ System Data Presented at New Cardiovascular Horizons Conference Shows Key Findings including Luminal Gain

TOLEDO, Ohio, June 4, 2019 /PRNewswire/ — VentureMed Group, Inc., a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced new data presented at the 20th Annual New Cardiovascular Horizons (NCVH) Annual Conference, May 29-31, in New Orleans, Louisiana. FLEX iDissection Study Results Presentation The study […]

GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects

FLAGSTAFF, Ariz., June 4, 2019 /PRNewswire/ — W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA) of the GORE® CARDIOFORM ASD Occluder for the percutaneous closure of ostium secundum atrial septal defects (ASDs). The FDA approval was supported by data collected from the pivotal stage of the Gore […]

AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc.

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it closed the previously announced sale of its NAMIC® fluid management portfolio to Medline Industries, Inc. on May 31, 2019 for $167.5 million. AngioDynamics has […]

BioSig Technologies Receives $4.6 Million in Cash Warrant and Option Exercises

Email Print Friendly Share June 03, 2019 07:52 ET | Source: BioSig Technologies, Inc. Santa Monica, CA, June 03, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it received a […]

Ancora Heart Enrolls First Patient in U.S. Early Feasibility Study of First-of-Its-Kind Investigational Heart Failure Therapy

SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the first patient was enrolled in a U.S. early feasibility study evaluating the AccuCinch® Ventricular Repair System as a treatment for patients with reduced ejection fraction systolic heart failure (HFrEF). The first patient […]